Brief: Imagion Biosystems Says FY Revenue Up 68.7% To A$5.2 Million
29/02/2024 06:14
Feb 29 (Reuters) - Imagion Biosystems Ltd IBX.AX :
* FY REVENUE UP 68.7% TO A$5.2 MILLION
* FY LOSS ATTRIBUTABLE A$13 MILLION
Source text for Eikon: ID:nASX8RSN1l
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt